FUJIFILM Diosynth Biotechnologies
A leading CDMO, with a focus is to combine technical leadership in cell culture, microbial fermentation and gene therapies with world class cGMP manufacturing facilities to advance tomorrow’s medicines.
Now part of a leading-edge collaborative project with the Centre for Process Innovation and Perceptive Engineering. David Lovett, Managing Director at Perceptive Engineering, said: “By using advances in at-line process analytical technology, the DIICbM project will help to optimise end-to-end manufacturing processes at CPI’s National Biologics Manufacturing Centre. With strategic guidance from world-leading partner FUJIFILM Diosynth Biotechnologies, we are hugely excited by this project.”
